Business
AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors
Published On : 2026-01-12
AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors
#Business
Business
Atara Biotherapeutics stock plunges after FDA rejects cancer therapy
Published On : 2026-01-12
Atara Biotherapeutics stock plunges after FDA rejects cancer therapy
#Business
Business
Bakkt agrees to acquire Distributed Technologies Research
Published On : 2026-01-12
Bakkt agrees to acquire Distributed Technologies Research
#Business
Discover more from Trend Teller
Subscribe to get the latest posts sent to your email.
Trend Teller 